AKT1 and neoplasm: Importantly, inhibition of either VEGFA or the PI3K/AKT/mTOR pathway reversed the increased migratory and invasive abilities of CRCs following CXCR6 silencing, highlighting the receptor’s key role in regulating tumor aggressiveness [125].